标题
Lysosomal storage diseases: current therapies and future alternatives
作者
关键词
-
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 98, Issue 7, Pages 931-946
出版商
Springer Science and Business Media LLC
发表日期
2020-06-11
DOI
10.1007/s00109-020-01935-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel gene editing system to treat both Tay–Sachs and Sandhoff diseases
- (2020) Li Ou et al. GENE THERAPY
- Genome Editing for Mucopolysaccharidoses
- (2020) Edina Poletto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CRISPR/Cas9 Editing for Gaucher Disease Modelling
- (2020) Eleonora Pavan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I
- (2020) Li Ou et al. MOLECULAR THERAPY
- Lysosomal storage disorders – challenges, concepts and avenues for therapy: beyond rare diseases
- (2019) André R. A. Marques et al. JOURNAL OF CELL SCIENCE
- Principles of gene editing techniques and applications in animal husbandry
- (2019) Shengwang Jiang et al. 3 Biotech
- Diversifying the structure of zinc finger nucleases for high-precision genome editing
- (2019) David E. Paschon et al. Nature Communications
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- EMPOWERS: A phase 1/2 clinical trial of SB-318 ZFN-mediated in vivo human genome editing for treatment of MPS I (Hurler syndrome)
- (2019) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- CHAMPIONS: A phase 1/2 clinical trial with dose escalation of SB-913 ZFN-mediated in vivo human genome editing for treatment of MPS II (Hunter syndrome)
- (2019) Joseph Muenzer et al. MOLECULAR GENETICS AND METABOLISM
- CRISPR/Cas9 technology as a potent molecular tool for gene therapy
- (2019) Ansar Karimian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury
- (2019) Mary T. Joy et al. CELL
- Ethics of Human Genome Editing
- (2019) Barry S. Coller Annual Review of Medicine
- Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy
- (2019) Song et al. Cells
- Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
- (2019) Kazuki Sawamoto et al. DRUGS
- Design and applications of gene therapy vectors for mucopolysaccharidosis in Colombia
- (2019) Carlos J. Alméciga-Diaz et al. GENE THERAPY
- Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA
- (2019) Carlos J. Alméciga-Diaz et al. JOURNAL OF MEDICINAL CHEMISTRY
- CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)
- (2019) S. L. Eaton et al. Scientific Reports
- Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model
- (2019) Kazuki Sawamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish
- (2019) Lindsey T. Lelieveld et al. JOURNAL OF LIPID RESEARCH
- Modeling Niemann–Pick disease type C in a human haploid cell line allows for patient variant characterization and clinical interpretation
- (2019) Steven Erwood et al. GENOME RESEARCH
- Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: Implications for in vivo end ex vivo gene therapy of GM2 gangliosidosis
- (2019) Francesca Ornaghi et al. NEUROBIOLOGY OF DISEASE
- Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
- (2019) Natalia Gomez-Ospina et al. Nature Communications
- Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice
- (2019) Roselena Silvestri Schuh et al. GENE THERAPY
- Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses
- (2019) Juan Camilo Losada Díaz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis
- (2019) Gemma Gomez-Giro et al. Acta Neuropathologica Communications
- Model construction of Niemann-Pick type C disease in zebrafish
- (2018) Yusheng Lin et al. BIOLOGICAL CHEMISTRY
- Genetics and Therapies for GM2 Gangliosidosis
- (2018) Maria Begona Cachon-Gonzalez et al. CURRENT GENE THERAPY
- 2-Hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1
- (2018) Pericles Calias CURRENT PHARMACEUTICAL DESIGN
- Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers
- (2018) Roselena Silvestri Schuh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene
- (2018) Arildo Nerys-Junior et al. GENETICS AND MOLECULAR BIOLOGY
- Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison
- (2018) Julie B Eisengart et al. GENETICS IN MEDICINE
- Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
- (2018) Myung Jong Kim et al. HUMAN MOLECULAR GENETICS
- Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation
- (2018) Maria L. Allende et al. JOURNAL OF LIPID RESEARCH
- Gene therapy for Mucopolysaccharidoses
- (2018) Kazuki Sawamoto et al. MOLECULAR GENETICS AND METABOLISM
- Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
- (2018) Kanut Laoharawee et al. MOLECULAR THERAPY
- Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases
- (2018) Ya-Xiong Tao et al. PHYSIOLOGICAL REVIEWS
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
- (2018) David M. Pereira et al. Chemical Science
- The Current State and Future of CRISPR-Cas9 gRNA Design Tools
- (2018) Laurence O. W. Wilson et al. Frontiers in Pharmacology
- Large-Scale Expansion of Human iPSC-Derived Skeletal Muscle Cells for Disease Modeling and Cell-Based Therapeutic Strategies
- (2018) Erik van der Wal et al. Stem Cell Reports
- Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform forin vivoscreening of candidate therapeutic compounds
- (2018) Wei-Chia Tseng et al. Disease Models & Mechanisms
- In Vivo Genome Editing as a Therapeutic Approach
- (2018) Beatrice Ho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
- (2018) Roselena Silvestri Schuh et al. JOURNAL OF CONTROLLED RELEASE
- Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy
- (2018) Roselena Silvestri Schuh et al. PHARMACEUTICAL RESEARCH
- Novel BUF2-magnetite nanobioconjugates with cell-penetrating abilities
- (2018) Monica Cuellar et al. International Journal of Nanomedicine
- Gene therapy for lysosomal storage diseases and peroxisomal diseases
- (2018) Toya Ohashi JOURNAL OF HUMAN GENETICS
- α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease
- (2018) Justin J. Kang et al. KIDNEY INTERNATIONAL
- Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B
- (2018) Michael J. Przybilla et al. MOLECULAR GENETICS AND METABOLISM
- Dissociation of globotriaosylceramide and impaired endothelial function in α-galactosidase-A deficient EA.hy926 cells
- (2018) Nayiri Kaissarian et al. MOLECULAR GENETICS AND METABOLISM
- ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome
- (2018) Li Ou et al. MOLECULAR THERAPY
- Sangamo's landmark genome editing trial gets mixed reception
- (2018) Cormac Sheridan NATURE BIOTECHNOLOGY
- (5a R )-5a- C- Pentyl-4- epi -isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B
- (2017) Sophie Front et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV
- (2017) Huiqing Li et al. HUMAN MOLECULAR GENETICS
- Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
- (2017) Rachele Penati et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Rad51-mediated double-strand break repair and mismatch correction of divergent substrates
- (2017) Ranjith Anand et al. NATURE
- Non-homologous DNA end joining and alternative pathways to double-strand break repair
- (2017) Howard H. Y. Chang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Open issues in Mucopolysaccharidosis type I-Hurler
- (2017) Rossella Parini et al. Orphanet Journal of Rare Diseases
- FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice
- (2017) Yasuhiro Ogawa et al. Scientific Reports
- Ethical and regulatory aspects of genome editing
- (2016) Donald B. Kohn et al. BLOOD
- Nanotechnology applied to treatment of mucopolysaccharidoses
- (2016) Roselena S. Schuh et al. Expert Opinion on Drug Delivery
- Preclinical Testing of the Safety and Tolerability of Lentiviral Vector–Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies
- (2016) Ilaria Visigalli et al. HUMAN GENE THERAPY
- Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing
- (2016) Xiangjin Kang et al. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
- Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
- (2016) Derralynn A Hughes et al. JOURNAL OF MEDICAL GENETICS
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs
- (2016) Calogera M. Simonaro et al. PLoS One
- Repair Pathway Choices and Consequences at the Double-Strand Break
- (2016) Raphael Ceccaldi et al. TRENDS IN CELL BIOLOGY
- Lysosomal Storage Diseases: From Pathophysiology to Therapy
- (2015) Giancarlo Parenti et al. Annual Review of Medicine
- Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy
- (2015) Bruna Donida et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model
- (2015) Carla Martins et al. BRAIN
- Zinc finger nuclease technology: Advances and obstacles in modelling and treating genetic disorders
- (2015) Hamid Reza Jabalameli et al. GENE
- Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1
- (2015) Pramod K. Mistry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial
- (2015) Timothy M Cox et al. LANCET
- Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
- (2015) Giancarlo Parenti et al. MOLECULAR THERAPY
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
- (2015) Puping Liang et al. Protein & Cell
- TALEN-mediated genome editing: prospects and perspectives
- (2014) David A. Wright et al. BIOCHEMICAL JOURNAL
- TALEN-Mediated Generation and Genetic Correction of Disease-Specific Human Induced Pluripotent Stem Cells
- (2014) Sivaprakash Ramalingam et al. CURRENT GENE THERAPY
- Pharmacological chaperone therapy for lysosomal storage diseases
- (2014) Giancarlo Parenti et al. Future Medicinal Chemistry
- Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
- (2014) Rajat M. Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Generation of knockout mice using engineered nucleases
- (2014) Young Hoon Sung et al. METHODS
- Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4
- (2014) Katharine J. Goodall et al. PLoS One
- Gene Therapy for Fabry Disease: A Review of the Literature
- (2013) Aritz Perez Ruiz de Garibay et al. BIODRUGS
- SunnyTALEN: A second-generation TALEN system for human genome editing
- (2013) Ning Sun et al. BIOTECHNOLOGY AND BIOENGINEERING
- Protein Misfolding in Disease and Small Molecule Therapies
- (2013) Claudio M. Gomes CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
- (2013) Robert E. Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- DNA targeting specificity of RNA-guided Cas9 nucleases
- (2013) Patrick D Hsu et al. NATURE BIOTECHNOLOGY
- A library of TAL effector nucleases spanning the human genome
- (2013) Yongsub Kim et al. NATURE BIOTECHNOLOGY
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
- (2013) Edward H. Schuchman et al. PLoS One
- Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis
- (2013) Z. Hou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A variant CRISPR-Cas9 system adds versatility to genome engineering
- (2013) R. M. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Enzyme Replacement Therapy for Lysosomal Diseases: Lessons from 20 Years of Experience and Remaining Challenges
- (2012) R.J. Desnick et al. Annual Review of Genomics and Human Genetics
- TALENs: a widely applicable technology for targeted genome editing
- (2012) J. Keith Joung et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
- (2012) Maarten Holkers et al. NUCLEIC ACIDS RESEARCH
- Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation
- (2012) A. Capotondo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs)
- (2012) Y. Lei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: The positive effect of long-term aspirin treatment
- (2011) Audrey Arfi et al. MOLECULAR GENETICS AND METABOLISM
- Targeted gene disruption in somatic zebrafish cells using engineered TALENs
- (2011) Jeffry D Sander et al. NATURE BIOTECHNOLOGY
- Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection
- (2011) Vikram Pattanayak et al. NATURE METHODS
- Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes
- (2011) Ting Li et al. NUCLEIC ACIDS RESEARCH
- Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI
- (2011) Efrat Eliyahu et al. PLoS One
- Molecular Mechanism of Cyclodextrin Mediated Cholesterol Extraction
- (2011) Cesar A. López et al. PLoS Computational Biology
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
- (2010) Michael R. Lieber Annual Review of Biochemistry
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model
- (2010) I. Visigalli et al. BLOOD
- Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy
- (2010) John Marshall et al. JOURNAL OF INHERITED METABOLIC DISEASE
- A TALE nuclease architecture for efficient genome editing
- (2010) Jeffrey C Miller et al. NATURE BIOTECHNOLOGY
- Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA)
- (2010) Jeffry D Sander et al. NATURE METHODS
- Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease
- (2010) John Marshall et al. PLoS One
- Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions
- (2009) Vinod K. Prasad et al. BRITISH JOURNAL OF HAEMATOLOGY
- Substrate reduction therapy in juvenile GM2 gangliosidosis
- (2009) Gustavo H.B. Maegawa et al. MOLECULAR GENETICS AND METABOLISM
- Miglustat in adult and juvenile patients with Niemann–Pick disease type C: Long-term data from a clinical trial
- (2009) James E. Wraith et al. MOLECULAR GENETICS AND METABOLISM
- Involvement of the Toll-like receptor 4 pathway and use of TNF- antagonists for treatment of the mucopolysaccharidoses
- (2009) C. M. Simonaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Substrate reduction therapy
- (2008) Frances M Platt et al. ACTA PAEDIATRICA
- Randomized, controlled trial of miglustat in Gaucher's disease type 3
- (2008) Raphael Schiffmann et al. ANNALS OF NEUROLOGY
- Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician’s perspective
- (2008) Mary Eapen et al. LIFETIME DATA ANALYSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search